Home Equities Score Why is  Altimmune, Inc. (ALT) stock popping high in Pre-Market trading?

Why is  Altimmune, Inc. (ALT) stock popping high in Pre-Market trading?

Altimmune, Inc. (ALT), a clinical stage biopharmaceutical company focused on developing treatments for liver disease and immune modulating therapies, announced the latest results from a preclinical study observing the ability of its AdCOVID vaccine candidate to neutralize the swift transmission of SARS-CoV-2 B.1.351 strain of concern that originated in South Africa.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

At last check, shares of Altimmune Inc. (ALT) were up 5.08% at $12.40. ALT stock closed last session at $11.80, decreasing -2.07% or -$0.25. Shares of the company fluctuated between $11.80 and $12.63 throughout the day. ALT shares have risen by 40.14% over the last 12 months, and they have moved down by -16.13% in the past week.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Financial Result First Quarter 2021

Revenue generated was $0.8 million for the first quarter of 2021versus $2.2 million in the previous quarter, depicting a decline of $1.4 million. The change in revenue quarter over quarter was offset due to a decline of $2.0 million in BARDA revenue during the current period due to the timing of clinical trials and development activities for NasoShield, partially offset by $0.5 million in revenue linked to T-COVID.

Research and development cost was $11.9 million for the first quarter of the current year in comparison to $7.2 million in the previous quarter, depicting an increment of $4.7 million. The change was offset by increased expenses of $5.4 million linked to development activities for the Company’s COVID-19 programs, offset by a decrease of $1.5 million resulting from a decline in the fair value of contingent consideration liability related with the acquisition and development of ALT-801.

General and administrative cost was $3.8 million for the first quarter of 2021in comparison to $2.3 million in the previous period, representing an increment of $1.5 million. The increment during the quarter was offset due to increased stock compensation expense and additional labor linked expenses.

Net loss for the first quarter of 2021 was $14.9 million, or $0.38 net loss per share, in comparison to $3.9 million in the previous period, or a $0.26 net loss per share. The difference in net loss is offset by higher research and development cost and general and administrative costs.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion

Positive top-line data regarding AdCOVID vaccine’s clinical study combined with a strong financial result surpassed shareholder expectations for  Altimmune, Inc, with ALT stock price rising immensely.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Aprea Therapeutics Inc. (APRE) stock soars during current market trading. What’s the update?

Aprea Therapeutics Inc. (NASDAQ: APRE) stock gained by 41.03% at the last check in the current market trading. Aprea Therapeutics is a pharmaceutical business...

Roblox Corp. (NASDAQ: RBLX) stock falls during pre-market trading session. What’s happening?

Roblox Corp. (NASDAQ: RBLX) stock gained by 2.28% at last close while the RBLX stock price declines by 8.13% in the pre-market trading session....

Can-Fite BioPharma Inc. (CANF) stock soars during current market. Why so?

Can-Fite BioPharma Inc. (NASDAQ: CANF) stock gained by 4.42% in the current market trading session. Can-Fite BioPharma Ltd. is a medication research company in...

UXIN stock surges during current market. Here’s to know why?

Uxin Ltd. (NASDAQ: UXIN) stock gains by 14.67% at last check during current market trading. In China, Uxin Limited is a prominent online used...

Opgen Inc. (OPGN) stock surged during pre-market session. What’s driving it high?

Opgen Inc. (NASDAQ: OPGN) stock declined by 1.84% at the last close whereas the OPGN stock price gains by 22.07% in the pre-market trading...

Aprea Therapeutics Inc. (APRE) stock soars during current market trading. What’s the update?

Aprea Therapeutics Inc. (NASDAQ: APRE) stock gained by 41.03% at the last check in the current market trading. Aprea Therapeutics is a pharmaceutical business...

TAL Education Group (TAL) stock is tumbling today: What’s Going on?

Shares of the TAL Education Group (TAL) stock were tumbling in the current market trading session today on June 16, 2021, without any obvious...

SPI Energy Inc. (SPI) stock surged in the current market trading. Here’s the update

SPI Energy Inc. (NASDAQ: SPI) stock soars by 15.42% during the current market trading session. SPI Energy is an international renewable energy company that...

Related News

Ocugen Inc. (OCGN) stock surged during pre-market trading session. Here’s what you should know?

Ocugen Inc. (NASDAQ: OCGN) stock gained by 2.12% at last close while the OCGN stock price soars during pre-market trading by 4.95%. Ocugen, Inc....

Avenue Therapeutics Inc. (ATXI) stock plunged during pre-market trading. What’s behind this?

Avenue Therapeutics Inc. (NASDAQ: ATXI) stock declined by 28.27% at last close while the ATXI stock price falls during pre-market as well, by 8.94%....

Unique Fabricating Inc. (UFAB) stock gains during pre-market trading. Let’s figure out why?

Unique Fabricating Inc. (NASDAQ: UFAB) stock declined by 1.21% at the last close while the UFAB stock price tends to rise by 40.67% in...

Torchlight Energy Resources Inc. (TRCH) stock soars during after-hour session. Let’s see why?

Torchlight Energy Resources Inc. (NASDAQ: TRCH) stock gained by 14.74% at last close while the TRCH stock price further rose by 16.48% in the...

Orphazyme A/S (ORPH) stock is Popping High in Pre-Market today: Here’s to know Why?

Shares of Orphazyme A/S (ORPH) stock were popping high in the pre-market today on June 14, 2021, after dropping with more than half of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam